ADAMTS9‐AS2 Disrupts Docetaxel‐Resistance in Castration‐Resistant Prostate Cancer via Stemness Suppression and Ferroptosis Induction
Advanced Science · 2026
DOI: 10.1002/advs.202520838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Ji Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, School of Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, P. R. China. Hauptthemen laut MEDLINE: Ferroptosis, Docetaxel, Prostatic Neoplasms, Castration-Resistant, Neoplastic Stem Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China Major Project, National Natural Science Foundation of China, Youth Project, Experimental Animal Fund of Shanghai Science and Technology Commission.
Abstract (Originalsprache)
Castration‐resistant prostate cancer (CRPC) chemotherapy resistance remained a significant clinical challenge. Prostate tumor stem cells (PCSCs) played a crucial role in chemotherapy resistance, but the underlying mechanisms were not fully understood. This study investigated how ADAMTS9‐AS2 reduced chemotherapy resistance in CRPC through a dual mechanism and explored the potential of polymeric materials targeting PCSCs and enhancing chemotherapy sensitivity. Key regulatory molecules of PCSCs were identified through mRNAsi‐based multi‐center patient cohorts. The effect of ADAMTS9‐AS2 on reducing docetaxel resistance in CRPC was assessed, and its mechanisms were further explored using in vitro and in vivo experiments. Finally, polymeric materials containing TGF‐β inhibitor, ferroptosis inducer, and miR‐182‐5p inhibitor were used to target PCSCs to improve chemotherapy sensitivity. ADAMTS9‐AS2 reduced CRPC chemotherapy resistance through dual mechanisms: (1) regulating FOXF2/TGF‐β2 axis to suppress PCSCs stemness; (2) encoding a short peptide that competitively retained more SLC7A11 in the cytoplasm than on the cytomembrane, thus promoting ferroptosis. Furthermore, polymeric materials targeting PCSCs significantly enhanced docetaxel sensitivity and inhibited tumor progression. ADAMTS9‐AS2 delayed docetaxel resistance by suppressing CRPC stemness and inducing ferroptosis. The use of polymeric materials targeting PCSCs offered a novel strategy to overcome CRPC chemotherapy resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, School of Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, P. R. China.
- School of Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, P. R. China.
- School of Chemical Science and Engineering, Department of Laboratory Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, P. R. China.
- The Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
ORCID-Profile: Ji Liu, Shuo Shi, Xudong Yao
Förderung
- National Natural Science Foundation of China Major Project
- National Natural Science Foundation of China, Youth Project
- Experimental Animal Fund of Shanghai Science and Technology Commission
- MJR Young Scientist Research Fund Grant
- Tongji University Medicine-X Interdisciplinary Research Initiative
Zitieren
APA
Liu, J., Gao, Y., Guo, Y., Zhang, J., Zhang, W., Gu, Z., Chen, H., Jin, C., Luo, P., Mao, S., Hao, Y., Shi, S., & Yao, X. (2026). ADAMTS9‐AS2 Disrupts Docetaxel‐Resistance in Castration‐Resistant Prostate Cancer via Stemness Suppression and Ferroptosis Induction. Advanced Science. https://doi.org/10.1002/advs.202520838
Vancouver
Liu J, Gao Y, Guo Y, Zhang J, Zhang W, Gu Z, et al. ADAMTS9‐AS2 Disrupts Docetaxel‐Resistance in Castration‐Resistant Prostate Cancer via Stemness Suppression and Ferroptosis Induction. Advanced Science. 2026. doi:10.1002/advs.202520838
BibTeX
@article{Liu2026,
author = {Liu, Ji and Gao, Yan and Guo, Yadong and Zhang, Junfeng and Zhang, Wentao and Gu, Zhuoran and Chen, Haotian and Jin, Chengqi and Luo, Peng and Mao, Shiyu and Hao, Yajuan and Shi, Shuo and Yao, Xudong},
title = {ADAMTS9‐AS2 Disrupts Docetaxel‐Resistance in Castration‐Resistant Prostate Cancer via Stemness Suppression and Ferroptosis Induction},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202520838}
}
EUVIMED